DOSE-CONVERSION FROM LT4 TO ARMOUR THYROID
., USA,[/i]
[i]4 Palm Beach Diabetes and Endocrine Specialists, P.A., USA,[/i]
[i]5 AbbVie, Inc., USA,[/i]
[i]6 AbbVie, Inc., USA,[/i]
[i]7 Section of Adult and Pediatric Endocrinology and Metabolism, University of Chicago, USA[/i]
[i]Objective: A phase 2 dose-conversion study (ARCH) which was recently
., USA,[/i]
[i]4 Palm Beach Diabetes and Endocrine Specialists, P.A., USA,[/i]
[i]5 AbbVie, Inc., USA,[/i]
[i]6 AbbVie, Inc., USA,[/i]
[i]7 Section of Adult and Pediatric Endocrinology and Metabolism, University of Chicago, USA[/i]
[i]Objective: A phase 2 dose-conversion study (ARCH) which was recently